Syncope, a transient loss of consciousness due to global cerebral hypoperfusion, is a common clinical presentation with a broad differential diagnosis. Its evaluation and management can be challenging due to its multifactorial etiology. This article aims to provide a comprehensive approach to understanding and managing syncope for healthcare professionals.
Syncope can be categorized into three broad categories: reflex, orthostatic hypotension, and cardiac. Reflex syncope, also known as neurally mediated syncope, includes vasovagal, situational, and carotid sinus syncope. Orthostatic hypotension is caused by a drop in blood pressure upon standing. Cardiac syncope can be due to arrhythmias or structural heart disease.
A thorough history and physical examination are paramount in the evaluation of syncope. Specific attention should be given to the circumstances surrounding the syncopal event, including prodromal symptoms, position during the event, and recovery period. Diagnostic tests should be guided by clinical suspicion based on the history and physical examination.
The management of syncope depends on the underlying cause. Reflex syncope is usually managed with lifestyle modifications and reassurance. Orthostatic hypotension may require medication adjustments, volume expansion, and physical counterpressure maneuvers. Cardiac syncope may necessitate medical or surgical interventions, including pacemaker implantation or cardiac ablation.
Syncope is a complex clinical entity that requires a comprehensive approach for effective evaluation and management. A thorough understanding of its etiology, pathophysiology, clinical evaluation, and management strategies is essential for healthcare professionals to ensure optimal patient care.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation